← Open Payments lookup

MASSOUD RASOOLI: Open Payments

NPI 1720587082 · GARLAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,514 in 82 payments from 14 companies in 2025. Trend: 2023 $416 · 2024 $731 · 2025 $1,514

Food & beverage: $1,514
CompanyPaymentsAmount
ABBVIE INC.38$575
Takeda Pharmaceuticals U.S.A., Inc.18$320
Ardelyx, Inc.10$230
Salix Pharmaceuticals, a division of Bausch Health US, LLC3$66
GENZYME CORPORATION2$60
RedHill Biopharma Inc.2$49
Madrigal Pharmaceuticals2$47
Braintree Laboratories, Inc.1$38
Regeneron Healthcare Solutions, Inc.1$33
Phathom Pharmaceuticals, Inc.1$24

Products named: RINVOQ, ENTYVIO, IBSRELA, LINZESS, DUPIXENT, SKYRIZI, XIFAXAN, Talicia.

Industry payments across TX — which companies pay providers there.